Evaluation of prevalence, clinical presentation and risk factors of coronary slow flow phenomenon: a single-center study


  • Shaileshkumar Patil Department of Cardiology, Ashwini Sahakari Rugnalaya, Rural Medical College and Research Centre, Solapur, Maharashtra, India
  • Achyut Sarkar Department of Cardiology, Institute of Post Graduate Medical Education and Research, Kolkata, West Bengal, India
  • Manisha Patil Diabetologist, Hrudayam Heart Clinic and Diabetes Centre, Solapur, Maharashtra, India
  • Imran Ahmed Department of Cardiology, Medical College of Kolkata, Kolkata, West Bengal, India
  • Arindam Pande Department of Cardiology, Medica Superspeciaity Hospital, Kolkata, West Bengal, India




Coronary angiography, Coronary slow flow, Homocysteine, Thrombolysis in myocardial infarction, Unstable angina


Background: The coronary slow flow phenomenon has been revealed to be associated with life-threatening arrhythmias and sudden cardiac death. Currently, clinical features and risk factors of patients with the coronary slow flow phenomenon are incompletely understood. The present study aimed to evaluate the prevalence, clinical presentation, risk factors and evidence of ischemia in patients with coronary slow flow.

Methods: This observational study was conducted at a tertiary-care center in India between February 2013 and August 2014.  A total of 60 consecutive patients whose coronary angiogram revealed coronary slow flow were included in the study. According to the number of blood vessels involved, patients were divided into group-1 (29 patients with single-vessel disease), group-2 (22 patients with double-vessel disease), and group-3 (9 patients with triple-vessel disease). Clinical presentation and risk factors were compared among groups.

Results: Prevalence of coronary slow flow was 2.97% with greater prevalence amongst male patients (p=0.030). Unstable angina was the most common presentation (p=0.030). Among the traditional risk factors, there was a significantly higher prevalence of smoking (p=0.036), family history of coronary artery disease (p=0.049) and dyslipidemia (p=0.045) in group-3 patients compared to other groups. Among all groups, triglycerides (p=0.020), low-density lipoprotein cholesterol (p=0.046), highly sensitive C-reactive protein (p=0.007) levels, homocysteine (p=0.481), and patterns of ECG abnormalities were significantly different between the three groups. In addition, mean frame counts with coronary slow flow phenomenon in left anterior descending artery (p<0.001), left circumflex artery (p<0.001) and right coronary artery (p=0.005) increased significantly with increase in number of vessels involved.

Conclusions: Coronary slow flow was relatively common among patients who presented with unstable angina. Male sex, smoking, and dyslipidemia can be considered as independent risk factors for this phenomenon.




Sanghvi S, Mathur R, Baroopal A, Kumar A. Clinical, demographic, risk factor and angiographic profile of coronary slow flow phenomenon: A single centre experience. Indian Heart J. 2018;70:S290-4.

Beltrame JF, Limaye SB, Horowitz JD. The coronary slow flow phenomenon–a new coronary microvascular disorder. Cardiology. 2002;97(4):197-202.

Demirkol MO, Yaymac B, Mutlu B. Dipyridamole myocardial perfusion single photon emission computed tomography in patients with slow coronary flow. Coron Artery Dis. 2002;13(4):223-9.

Tambe A, Demany M, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J. 1972;84(1):66-71.

Gibson CM, Cannon CP, Daley WL, Dodge Jr JT, Alexander B, Marble SJ et al. TIMI frame count: A quantitative method of assessing coronary artery flow. Circulation 1996;93(5):879-88.

Alvarez C, Siu H. Coronary slow-flow phenomenon as an underrecognized and treatable source of chest pain: Case series and literature review. J Investig Med High Impact Case Rep. 2018;6:2324709618789194.

Kelly RF, Sompalli V, Sattar P, Khankari K. Increased TIMI frame counts in cocaine users: A case for increased microvascular resistance in the absence of epicardial coronary disease or spasm. Clin Cardiol. 2003;26(7):319-22.

Cutri N, Zeitz C, Kucia AM, Beltrame JF. ST/T wave changes during acute coronary syndrome presentation in patients with the coronary slow flow phenomenon. Int J Cardiol. 2011;146(3):457-8.

Wożakowska-Kapłon B, Niedziela J, Krzyżak P, Stec S. Clinical manifestations of slow coronary flow from acute coronary syndrome to serious arrhythmias. Cardiol J. 2009;16(5):462-8.

Atak R, Turhan H, Sezgin AT, Yetkin O, Senen K, Ileri M et al. Effects of slow coronary artery flow on QT interval duration and dispersion. Ann Noninvasive Electrocardiol. 2003;8(2):107-11.

Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn. 1996;37(4):375-81.

Herrmann J, Kaski JC, Lerman A. Coronary microvascular dysfunction in the clinical setting: From mystery to reality. Eur Heart J. 2012;33(22):2771-83.

Li J-J, Xu B, Li Z-C, Qian J, Wei B-Q. Is slow coronary flow associated with inflammation? Med Hypotheses. 2006;66(3):504-8.

Cheitlin MD, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davis JL et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003;42(5):954-70.

Vilcant V, Zeltser R. Treadmill Stress Testing. StatPearls. 2018.

Hawkins BM, Stavrakis S, Rousan TA, Abu-Fadel M, Schechter E. Coronary slow flow. Circ J. 2012;76(4):936-42.

Arbel Y, Rind E, Banai S, Halkin A, Berliner S, Herz I et al. Prevalence and predictors of slow flow in angiographically normal coronary arteries. Clin Hemorheol Microcirc. 2012;52(1):5-14.

Goel PK, Gupta SK, Agarwal A, Kapoor A. Slow coronary flow: a distinct angiographic subgroup in syndrome X. Angiol. 2001;52(8):507-14.

Erbay AR, Turhan H, Yasar AS, Ayaz S, Sahin O, Senen K, et al. Elevated level of plasma homocysteine in patients with slow coronary flow. Int J Cardiol. 2005;102(3):419-23.

Xia S, Deng S-B, Wang Y, Xiao J, Du J-L, Zhang Y, et al. Clinical analysis of the risk factors of slow coronary flow. Heart Vessels. 2011;26(5):480-6.

Wang X, Nie S-P. The coronary slow flow phenomenon: characteristics, mechanisms and implications. Cardiovasc Diagn Ther. 2011;1(1):37.

Çanga A, Kocaman SA, Çetin M, Durakoglugil E, Erdogan T, Çiçek Y. Relationship between leukocyte and subtype counts, low-grade inflammation and slow coronary flow phenomenon in patients with angiographically normal coronary arteries. Acta Cardiol Sin. 2012;28(4):306-14.

Moazenzadeh M, Abbaszadeh M, Sarvar Azimzadeh B, Rashidinezhad HR. Comparison of plasma level of hs-CRP in subjects with slow coronary flow and normal coronary flow. J Tehran Heart Cent. 2012;13(1):17-22.

Acikel S, Bozkaya OA, Akdemir R. The relationship between intermittent left bundle-branch block and slow coronary flow in a patient presenting with acute coronary syndrome. Blood Coagul Fibrinolysis. 2010;21(6):595-7.

Fineschi M, Gori T. Coronary slow-flow phenomenon or syndrome Y: A microvascular angina awaiting recognition. J Am Coll Cardiol. 2010;56(3):239-40.

Cesar L, Ramires J, Serrano CJ, Meneghetti J, Antonelli R, Da-Luz P, et al. Slow coronary run-off in patients with angina pectoris: Clinical significance and thallium-201 scintigraphic study. Braz J Med Biol Res. 1996;29(5):605-13.




How to Cite

Patil, S., Sarkar, A., Patil, M., Ahmed, I., & Pande, A. (2021). Evaluation of prevalence, clinical presentation and risk factors of coronary slow flow phenomenon: a single-center study. International Journal of Research in Medical Sciences, 9(4), 1106–1111. https://doi.org/10.18203/2320-6012.ijrms20211359



Original Research Articles